US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.07

+0.00460.01%

Volume:849

Turnover:29.75K

Market Cap:16.48M

PE:- -

High:35.07

Open:35.00

Low:35.00

Close:35.06

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.43

T/O Rate:0.18%

Dividend:0.41

Dividend Rate:1.17%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

ProQR Therapeutics doses first participant in AX-0811 clinical trial

Bayer initiates Phase II study of BAY 3670549 in patients with AFib

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

RBC Initiates Novartis at Sector Perform With CHF120 Price Target

MT Newswires Live

Evotec initiates clinical trial evaluating JST-018

Novartis's Stock Selloff Looks Overdone

Novartis Faces Sales Hole in Early 2030s After Trial Setback

Amgen Shares Plunge to Decade Low After Rival Drug Trial Fails, BMO Cuts Rating

How Traditional Chinese Medicine Is Moving From Ancient Recipes to Evidence-Based Data

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

European Shares Steady as Drugmaker Rout Offsets Commodity Strength

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Asia Morning Call-Global Markets

US Equity Markets End Lower After Houthi Attack on Saudi Arabia Energy Facilities

MT Newswires Live

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Headlands Research Names Brandon Pallott Chief Commercial Officer

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/MEDX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.065,"timestamp":1789151162091,"preClose":35.0604,"halted":0,"volume":849,"delay":0,"changeRate":0.000131202153996999,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Trading","change":0.0046,"latestTime":"09-11 14:29:28 EDT","open":35.001,"high":35.065,"low":35.001,"amount":29750.618946,"amplitude":0.001825,"askPrice":35.12,"askSize":700,"bidPrice":34.88,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":35.0604,"sharesOutstanding":569946,"nav":35.21,"aum":16546798.66,"dividendRate":0.011698,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.2396,"preClose":35.0604,"latestTime":"16:10 EDT","volume":6,"amount":210.2016,"timestamp":1789071007727,"change":0.1792,"changeRate":0.005111,"amplitude":0},"volumeRatio":0.426567},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.426567,"shares":469946,"dividePrice":0.4102,"high":35.065,"amplitude":0.001825,"preClose":35.0604,"low":35.001,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.065,"eps":0,"divideRate":0.011698,"volume":849,"delay":0,"ttmEps":0,"open":35.001,"prevYearClose":33.2024,"prevWeekClose":36.6906,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":37.0834,"twentyDayClose":35.9599,"sixtyDayClose":34.1895},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666538091","title":"ProQR Therapeutics doses first participant in AX-0811 clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538091?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956125,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics (PRQR) announced that the first participant has been dosed in the Phase 1 clinical trial of AX-0811 in healthy volunteers. Publi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/proqr-therapeutics-doses-first-participant-in-ax-0811-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/proqr-therapeutics-doses-first-participant-in-ax-0811-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","LU2360107671.USD","BK4139","AX","PRQR","LU1861217088.USD","MEDX","BK4539","GDOC","BK4195","IDNA","LU1861220207.SGD","NVIB","HYLG","BK4007","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538313","title":"Bayer initiates Phase II study of BAY 3670549 in patients with AFib","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538313","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538313?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:45","pubTimestamp":1788954315,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced the initiation of a global Phase II clinical trial evaluating BAY 3670549, an investigational highly selective G-protein-co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-initiates-phase-ii-study-of-bay-3670549-in-patients-with-afib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-initiates-phase-ii-study-of-bay-3670549-in-patients-with-afib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAY","BAYRY","GDOC","HYLG","MEDX","NVIB","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858794","title":"Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858794","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858794?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358477/24675/en/fate-therapeutics-announces-encore-clinical-data-presentation-of-ft819-off-the-shelf-car-t-cell-product-candidate-at-the-ccr-west-2026-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","MEDX","BK4139","NVIB","GDOC","BK4077","FATE","HYLG","SLE","CCR","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587949","title":"Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587949","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587949?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"OPGx-BEST1 demonstrated a favorable safety and tolerability profile with no serious adverse events or dose-limiting toxicities observed All five participants demonstrated clinically meaningful improve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358458/0/en/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-1-2-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MEDX","IDNA","ARB","GDOC","NVIB","BK4588","HYLG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558799","title":"Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558799","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558799?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience (Nasdaq: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle d","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358479/0/en/satellos-announces-forazapadin-as-assigned-international-nonproprietary-name-for-lead-drug-candidate-sat-3247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","GDOC","INN","MEDX","BK4218","IDNA","BK4181","HYLG","SAT","NVIB","DBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666847965","title":"RBC Initiates Novartis at Sector Perform With CHF120 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666847965","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666847965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:29","pubTimestamp":1788949792,"startTime":"0","endTime":"0","summary":"Novartis's (NVS) Swiss stock has an average rating of hold and mean price target of CHF125.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0070302665.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","PPH","IE0002141913.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4007","BK4585","NVS","BK4578","IE00B4R5TH58.HKD","BK4532","BK4588","MEDX","IE00BJJMRZ35.SGD","LU0211331839.USD","IE00B2B36J28.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589922","title":"Evotec initiates clinical trial evaluating JST-018","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589922","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589922?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:15","pubTimestamp":1788945324,"startTime":"0","endTime":"0","summary":"Evotec (EVO) announced the initiation of a Phase 1 clinical trial evaluating JST-018, a cocktail of investigational monoclonal antibodies targeting...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evotec-initiates-clinical-trial-evaluating-jst-018-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evotec-initiates-clinical-trial-evaluating-jst-018-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","MEDX","BK4121","HYLG","IDNA","NVIB","EVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666854435","title":"Novartis's Stock Selloff Looks Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2666854435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666854435?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:24","pubTimestamp":1788942240,"startTime":"0","endTime":"0","summary":"0823 GMT - Novartis's stock selloff on the failure of a neuromuscular drug in a clinical trial looks overdone and upcoming study results could be more positive for the Swiss drugmaker, Citi analysts say in a research note. The company reiterated its 2025-2030 outlook and trial setbacks for experimental neuromuscular and heart drugs del-desiran and pelacarsen are partially mitigated by the success of its remibrutinib medicine in a multiple sclerosis study, the analysts say. Full data for the MS study and results from another trial for the same drug in skin condition hidradenitis suppurativa could play in Novartis's favor, they add. Citi cuts its target price on Novartis stock to 135 Swiss francs from 142 francs. Shares fall 1.1% to 110.54 francs, after closing 11% lower Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NVS","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","PPH","IE0002141913.USD","IE0009355771.USD","LU0070302665.USD","MEDX","BK4588","BK4532","IE00BFTCPJ56.SGD","BK4007","BK4578","LU0320765489.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158379","title":"Novartis Faces Sales Hole in Early 2030s After Trial Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158379","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666158379?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:01","pubTimestamp":1788940860,"startTime":"0","endTime":"0","summary":"0801 GMT - Novartis's latest clinical-trial setback raises questions about the Swiss drugmaker's acquisition track record and leaves a sales hole to be plugged in the early 2030s, Deutsche Bank's Emmanuel Papadakis says in a research note. News that drug candidate del-desiran missed the target of a late-stage study in rare neuromuscular disorder known as myotonic dystrophy type 1 came shortly after cardiovascular drug pelacarsen failed another trial. Del-desiran was the first proof point for the recent $12 billion Avidity acquisition, the analyst says. Moreover, it leaves a hole to be addressed in the early 2030s when big drugs like Cosentyx, Kisqali and Kesimpta lose patent protection, he adds. Deutsche Bank cuts its recommendation on Novartis stock to hold from buy and trims its target price to 120 Swiss francs from 140 francs. Shares fall 0.8% to 110.86 francs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Novartis Faces Sales Hole in Early 2030s After Trial Setback","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","PPH","NVS","IE00B4R5TH58.HKD","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4588","LU0070302665.USD","BK4585","LU0208291251.USD","IE00B2B36J28.USD","BK4578","BK4007","IE00BJJMRZ35.SGD","MEDX","LU0211331839.USD","IE0002141913.USD","BK4532","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189130455","title":"Amgen Shares Plunge to Decade Low After Rival Drug Trial Fails, BMO Cuts Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1189130455","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189130455?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:48","pubTimestamp":1788936492,"startTime":"0","endTime":"0","summary":"Amgen shares tumbled more than 10% on Tuesday, marking their worst single-day decline since 2016, after Novartis AG revealed that a heart disease therapy it is developing with Ionis Pharmaceuticals...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","SG9999001440.SGD","LU0070302665.USD","LU0868494617.USD","LU1061106388.HKD","LU0320765489.SGD","AMGN","IE00BFTCPJ56.SGD","PPH","LU1057294990.SGD","LU0320765992.SGD","PBE","IE0002141913.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4139","LU0058720904.USD","LU2089984988.USD","LU2242646821.SGD","LU2112291526.USD","BK4007","BK4585","NVS","LU2242652126.USD","BK4578","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4532","BBH","BK4533","BK4588","BK4599","LU1983299246.USD","LU0889565916.HKD","LU0289739699.SGD","TBXU","MEDX","IBBQ","LU1023059063.AUD","BK4566","IE00BJJMRZ35.SGD","PJP","LU0211331839.USD","BIB","IE00B2B36J28.USD","LU0122379950.USD","LU0109394709.USD","LU1571399168.USD","LU0208291251.USD","BK4534","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186275720","title":"How Traditional Chinese Medicine Is Moving From Ancient Recipes to Evidence-Based Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1186275720","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186275720?lang=en_us&edition=fundamental","pubTime":"2026-09-09 07:41","pubTimestamp":1788910867,"startTime":"0","endTime":"0","summary":"Traditional Chinese Medicine (TCM) has long been built on the accumulated wisdom of generations of physicians. However, when measured against the rigorous standards of modern medicine, the industry...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","MEDX","BK4159","BK1161","RCT","IBBQ","LNGR","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370615","title":"Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370615?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:10","pubTimestamp":1788901814,"startTime":"0","endTime":"0","summary":"Atai Beckley holds shareholder meeting, quorum met with 65.6% shares representedAtai Beckley held a virtual special shareholder meeting on Sept. 8, 2026 to vote on a merger agreement with Eli Lilly.Sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1JLSHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014880.SGD","LU2896262040.SGD","FTXH","LLYX","LU0456855351.SGD","IE0001KFT4U8.USD","LU1712237335.SGD","LU0234572021.USD","BK4585","LLII","LU1145028129.USD","LU1548497426.USD","LU2112291526.USD","RXL","SGXZ99366536.SGD","LU0683600562.USD","ELIS","LU2602419157.SGD","WDNA","LU0094547139.USD","LU0320765992.SGD","LU2168564149.EUR","IE00B4JS1V06.HKD","SGXZ51526630.SGD","SG9999015952.SGD","LU2361044865.SGD","LU1623119135.USD","LU2237443978.SGD","TRUH","CURE","LU0133085943.USD","LU0238689110.USD","IE0004445015.USD","TMED","LU2168564065.EUR","LU2361044949.HKD","SGXZ31699556.SGD","LU1267930730.SGD","ELIL","LU0823434740.USD","LU2462157665.USD","LU1720051108.HKD","LU2023250504.SGD","LU1979441026.SGD","LU1868837136.USD","BK4533","FHLC","IE0004445239.USD","LU0198837287.USD","LU2471134523.USD","LU2491049909.HKD","LU2360106947.USD","SG9999014898.SGD","SG9999015945.SGD","SG9999018857.SGD","LU1983299246.USD","LU2237438978.USD","GB00BDT5M118.USD","LU0256863811.USD","LU1323610961.USD","SG9999015986.USD","IE00BKDWB100.SGD","LU2106854487.HKD","LU0061475181.USD","IE0009355771.USD","BK4516","LU0786609619.USD","LU2237443465.HKD","LU2271345857.HKD","LU0820562030.AUD","LU0158827781.USD","IE00BKPKM429.USD","LU0820561909.HKD","LU1691799644.USD","LU2461242641.AUD","LU0006306889.USD","SGXZ57979304.SGD","CANC","IE00B2B36J28.USD","LU0672654240.SGD","BK4599","LU2471134796.USD","SG9999013999.USD","LU0689472784.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU2168563687.JPY","LU1232071149.USD","LU2361045086.USD","IE00B775H168.HKD","LU1868836757.USD","LU0122379950.USD","LU0058720904.USD","LU1064131342.USD","LU2746668461.USD","PPH","IE00B1BXHZ80.USD","LU0096364046.USD","LU2491050154.USD","IE00BK4W5M84.HKD","LU2108987350.USD","LU2168564222.USD","LU2746668974.SGD","VHT","LU1551013342.USD","LU0106261372.USD","SG9999001176.USD","IYH","LU0174119429.USD","LU0466842654.USD","BK4007","LU2552382215.SGD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU0345770308.USD","LU1974910355.USD","LU2265009873.SGD","LU2211815571.USD","GDOC","IE00BFSS7M15.SGD","LU0943347566.SGD","LU1061106388.HKD","LU1989771016.USD","LU1291159041.SGD","LU0097036916.USD","LU0385154629.USD","LU2237443382.USD","LU2471134952.CNY","LU1280957306.USD","AGNG","IE00BWXC8680.SGD","LU0210536198.USD","LU2417539215.USD","LU0823416689.USD","SG9999015978.USD","IE0002141913.USD","LU0114720955.EUR","LU0289739699.SGD","LU0323591593.USD","LU0109394709.USD","LU2028103732.USD","BK4534","LU0079474960.USD","IXJ","LU1023059063.AUD","LU1093756325.SGD","LU0417517546.SGD","LU1629891620.HKD","LU2089283258.USD","PJP","LU1093756168.USD","LU2552382058.USD","SG9999014906.USD","LU2264538146.SGD","LU1720051017.SGD","SG9999018865.SGD","IHE","LU0203202063.USD","SG9999017495.SGD","LU0354030438.USD","LU0471298694.HKD","XLV","ATAI","LU1551013425.SGD","LU2087625088.SGD","LU2750360997.AUD","BK4581","LU2236285917.USD","IE00BJT1NW94.SGD","HRTS","LU0882574139.USD","SG9999014914.USD","MEDX","LU1917777945.USD","MEDI","LU0471298777.SGD","LU0320765059.SGD","LU2023250330.USD","IE00B4R5TH58.HKD","JDOC","IE00BFSS8Q28.SGD","THNR","LU0353189680.USD","LU1868837300.USD","LU2237443549.SGD","IE00BJJMRY28.SGD","LU0820561818.USD","SG9999001176.SGD","LU2491050071.SGD","IE00B7KXQ091.USD","LU2237443622.USD","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2750360641.GBP","LU0823434583.USD","LU0353189763.USD","LU1868836591.USD","LLY","LU1069344957.HKD","LU2089284900.SGD","LU2023251221.USD","ILDR","LU0787776722.HKD","LU2462591350.SGD","MHIP","IE00BN29S564.USD","LU0316494557.USD","LU0432979614.USD","LU1868836914.USD","LU2237443895.HKD","LU0256863902.USD","LU0203201768.USD","LU2468319806.SGD","LU2552382132.HKD","LU0354030511.USD","LU2756315664.SGD","LU2324357040.USD","LU1035775433.USD","OZEM","LU1366192091.USD","LU0345770993.USD","LU0964807845.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0109391861.USD","LU1127390331.HKD","LU1804176565.USD","LU1814569148.SGD","BK4539","LU0889565916.HKD","LU0158827948.USD","LLYZ","LU0266013472.USD","LU2063271972.USD","LU2089984988.USD","LU2471134879.HKD","IE00BFTCPJ56.SGD","LU2111349929.HKD","LU2756315318.SGD","IE00B1XK9C88.USD","LU2213496289.HKD","BK4588","LU2168564495.EUR","LU0225283273.USD","LU2456880835.USD","LU0640476718.USD","LU1988902786.USD","IE0005OL40V9.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131780980","title":"European Shares Steady as Drugmaker Rout Offsets Commodity Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=1131780980","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131780980?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:52","pubTimestamp":1788900732,"startTime":"0","endTime":"0","summary":"European equity markets found their footing on Tuesday, with the benchmark index holding its ground even as a heavyweight pharmaceutical firm experienced a record slump.The Stoxx Europe 600 index...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IJAN","IMFL","NBIE","DBEF","YDEC","IVSI","LU0320765489.SGD","RINT","REFA","PIZ","GLOF","TLTD","IOCT","LU0070302665.USD","BK4007","GSEU","INOV","ACWX","RODM","DFIC","FEOE","BKCI","EFO","GLBL","IE00BFTCPJ56.SGD","LU0211331839.USD","IFV","BK4550","YMAR","IDME","PTIN","VEA","ISEP","SCHF","TPIF","TOUS","ARLI","IAUG","TOK","BK4020","FEZ","IEFA","BK4167","JPIN","EWN","IDMY","TXUE","PIEQ","VNIE","KOKU","FSZ","IE00BJJMRZ35.SGD","PPH","BUFI","ISWN","CEFA","BBIN","QBIV","PTEU","IE0009355771.USD","WWJD","XEUR","IDUB","AVSD","RAYD","SPEU","INTF","IMAY","UIVM","DWMF","EAFG","IE0002141913.USD","BKIE","IE00B2B36J28.USD","MFDX","ICPY","IE00B4R5TH58.HKD","SSXU","XEML","DMXU","JULI","LU0208291251.USD","DFAI","HAWX","PPIE","GSIE","VIDI","BK4504","IMAR","BAIV","RODE","ITOL","IVAL","EURL","IFEB","IQLT","OVF","NUDM","IDMO","PXF","SEIE","RFDI","ISDX","PDEV","IDJN","QLVD","DFAX","STXI","IAPR","FLEE","PZIV","ICOW","ESIM","APIE","IMOM","TACN","VEFA","BK4534","EPIN","FDEV","JDVI","EFA","IDEQ","FFDI","IGGY","IJUN","JIRE","DXIV","QBIF","XW","CGIC","OEFA","MFSI","SPDW","MEDX","AVDE","OPPE","EASG","IXUS","JANI","RFEU","DTAN","EFAX","GSID","DINT","EUDG","BK4588","IEUR","AVIV","FEP","EFZ","BINV","BRIE","ENHI","IMTM","MOTI","HFXI","DBEU","FINT","VEU","TDI","TIIV","DDWM","TLCI","BUFY","CWI","BK4582","GXUS","IBUF","HEFA","FDT","BK4532","CGIE","IE00BJT1NW94.SGD","CGXU","IEV","WCMI","FHIL","DMXF","NIHI","WCMG","OAIM","IFLR","ILOW","PGRI","IJUL","VGK","BK4585","CVIE","BK4581","NVS","TILC","FEDM","IQSI","UPV","RDMX","QEFA","EPV","BK4578","GIEQ","YSEP","BBEU","FIEE","JHMD","IQDF","FENI","DEEF","IDEC","AVNM","URTH","PQIN","AIVI","IDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666243377","title":"Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666243377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666243377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:38","pubTimestamp":1788899880,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  slid 1.89% to $92.39 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.The stock's fall snapped a four-day winning streak.Medtronic PLC closed 13.11% below its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Danaher Corp.  fell 1.17% to $205.23, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  eclipsed its 50-day average volume of 7.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","DHR","BK4534","VHT","IE000WAW04H5.SGD","LU1061106388.HKD","LU0162691827.USD","BMED","LU0158827781.USD","MDT","IYH","SG9999013999.USD","LU0496365809.HKD","LU0289960550.SGD","SG9999002232.USD","IE00BJT1NW94.SGD","ABT","IHI","RXL","LU2129689431.USD","TMED","LU2211814178.USD","XLV","LU1261432733.SGD","TRUH","LU0234572021.USD","LU1721429741.USD","LU1791710400.SGD","MEDX","LU1023059063.AUD","LU1989763690.USD","FMED","FTXH","JNJ","FHLC","LU0320765059.SGD","LU1280957306.USD","LU1670627923.USD","LU0170899867.USD","LU1894683348.USD","PJP","IE00BN8TJ469.HKD","LU2063271972.USD","LU2125910179.SGD","LU0122379950.USD","GDOC","IHE","IE00B3T34201.USD","JDOC","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377919","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377919?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:30","pubTimestamp":1788899401,"startTime":"0","endTime":"0","summary":"UPDATE 1-Asia Morning Call-Global MarketsSept 9 (Reuters)-Stock MarketsNet ChngStock MarketsNet ChngS&P/ASX 200**8920.8-90.1NZX 50**13792.9-149.93DJIA**52828.61-585.64NIKKEI**65269.33-1130.51Nasdaq**2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4501KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["82800","07300","LU1951200564.SGD","PPH","BK0188","BK4578","LU1551013342.USD","SBIT","BK4548","BK4579","LU2361044949.HKD","FBTC","ARKB","LU0211331839.USD","CBTA","LU0052756011.USD","LU0689472784.USD","LU0130518102.USD","LU2357305700.SGD","LU1804176565.USD","LU0211327993.USD","LU0719512351.SGD","BK4608","LU2286300806.USD","MHImain","BK0187","LU0648000940.SGD","IE00BQXX3C00.GBP","LU0528227936.USD","LU1807302812.USD","BTCI","BK4581","LU1366333091.USD","LU1580142542.USD","BFAP","LU1988902786.USD","BK4588","LU0289961442.SGD","BPI","CBTO","LU0820561818.USD","BFJL","HSI","LU0472753341.HKD","LU1720051017.SGD","LU2458330243.SGD","LU0109392836.USD","HSTECH","BTCL","CBTY","LU0320765489.SGD","BK0028","03419","BCCC","GCPU","BTF","IE00B19Z8W00.USD","LU1791710400.SGD","LU0353189680.USD","LU0557290698.USD","NVS","07200","DJIA","000001","LU1316542783.SGD","LU0792757196.USD","03037","BTC.USD.CC","IE00B19Z8X17.USD","LU1235294995.USD","LU0157215616.USD","LU0211328371.USD","BITI","LU0130102774.USD","BK0183","EZBC","LU2265009873.SGD","IE00BFTCPJ56.SGD","LU0124676726.USD","03115","HODL","LU2244417387.USD","LU0501845795.SGD","LU0820562030.AUD","02800","CBXA","LU0106261372.USD","LU1923623000.USD","02833","LU0889565833.HKD","IE00BKVL7J92.USD","IBIT","YBTC","LU1496350502.SGD","CBOY","IE00BQXX3F31.USD","IE00BJJMRZ35.SGD","LU0889566641.SGD","BETH","BITY","BK0278","LU1803068979.SGD","IE0002141913.USD","LU0082616367.USD","LU1267930813.SGD","LU2087625088.SGD","IE00B19Z9505.USD","LU0251142724.SGD","BK4567","LU0267386448.USD","CBXY","LU0081259029.USD","LU0642271901.SGD","LU1551013425.SGD","LU2361045086.USD","LU0006306889.USD","LU2756315664.SGD","LU0128525689.USD","MNRS","BK4613","BK4528","IE00B4R5TH58.HKD","BK4607","83115","LU0353189763.USD","LU1791710582.SGD","BK4550","CBXJ","BITX","MAXI","IE00BJT1NW94.SGD","XKO.AU","CBOJ","BRRR","QBF","LU0742534661.SGD","LU0943347566.SGD","BK0201","MCHmain","LU0511384066.AUD","LU1064131342.USD","CBXO","BK4561","LU0314104364.USD","BK4538","LU1267930490.SGD","XAO.AU","CBOO","LU0880133367.SGD","LU0067412154.USD","LU1226287529.USD","XJO.AU","DEFI","BK4585","GBTC","LU0069063385.USD","LU0251131958.USD","LU2756315318.SGD","LU0130517989.USD","LU0354030511.USD","LU1720051108.HKD","BK4023","STI.SI","LU0238689110.USD","IE0009355771.USD","BETE","BTCC","09115","LU0689626769.HKD","LU1201861165.SGD","07500","LU1823568750.SGD","LU2236285917.USD","BK4534","LU0354030438.USD","LU0048573561.USD","LU1993786604.SGD","LU0234570918.USD","LU2461242641.AUD","BK4535","IE00BZ1G4Q59.USD","LU1989764748.USD","LU1655091616.SGD","BK4527","CBTJ","LU0127658192.USD","LU0310799852.SGD","BK0012","LU0980610538.SGD","DFII","LU1496350171.SGD","BK4543","HHImain","LU1951198990.SGD","BAGY","LU2247934214.USD","LU0130103400.USD","LU2361044865.SGD","LU1989764664.SGD","BITU","LU0310800965.SGD","LU0477156797.USD","513600","LU1814569148.SGD","LU0208291251.USD","BITO","BK4007","LU0477156953.USD","CBOA","IE00B0JY6N72.USD","LU0234572021.USD","CRMG","XBTY","ES3.SI","BTCZ","IE00BJTD4N35.SGD","LU0820561909.HKD","IE00B2B36J28.USD","LU1201861249.SGD","LU0057025933.USD","BITB","LU1781817850.SGD","LU1046421795.USD","IE00BJTD4V19.USD","BTCW","BTRN","BK4505","LU1267930227.SGD","BK4532","LU0070302665.USD","MEDX","LU0187121727.USD","LU0648001328.SGD","LU0198837287.USD","LU0289739343.SGD","BTC","IE00BQXX3D17.EUR","LU1548497426.USD","LU2264538146.SGD","LU2458330169.SGD","BK4598","LU0072913022.USD","CRM","BTCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666324377","title":"US Equity Markets End Lower After Houthi Attack on Saudi Arabia Energy Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2666324377","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666324377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:15","pubTimestamp":1788898507,"startTime":"0","endTime":"0","summary":"US equity indexes ended lower Tuesday after an Iran-backed militia group attacked Saudi Arabian energy sites, pushing crude oil and government bond yields higher.* Yemen's Houthis attacked energy faci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089985449.USD","LU0149725797.USD","LU1023059063.AUD","IBBQ","IE0000B7K699.USD","BK4535","IBB","BK4534","AIQ","TTEQ","LU2764263039.SGD","04332","LU2360106780.USD","INTW","BBH","BK4588","LINT","LU0070302665.USD","IE000BZT7R73.USD","NVS","BK4602","FTXL","LU0251131958.USD","XNTK","BK4579","LU0154236417.USD","IE000SO60NU8.SGD","BK4512","PJP","BK4007","LU0289739699.SGD","BK4581","BK4612","LU0109394709.USD","LU2764262908.HKD","LEGR","LU0889565916.HKD","LU0056508442.USD","IE000MB6IJN5.SGD","BK4566","LU2720916845.USD","MEDX","SG9999001440.SGD","LU0251142724.SGD","BK4139","IE00B2B36J28.USD","INYY","IE00B4R5TH58.HKD","PBE","HK0000304797.USD","BK4578","LU0320765992.SGD","LU1852331112.SGD","IE00BFTCPJ56.SGD","LU0321505868.SGD","BK4141","LU0321505439.SGD","LU2250418816.HKD","BK4543","BK4532","BK4554","BK4527","LU2112291526.USD","IE000M9KFDE8.USD","LU0081259029.USD","LU1061106388.HKD","LU0320765489.SGD","LU2543165471.USD","LU2931357623.SGD","LU0122379950.USD","IE0002141913.USD","LU2089984988.USD","IE000WAW04H5.SGD","LU2764263203.CNY","TBXU","BK4515","DRIV","LU0048573561.USD","LU0274383776.USD","LU1057294990.SGD","BK4599","LU0058720904.USD","LU2244417387.USD","04335","LU1983299246.USD","SINTCmain","LU0082616367.USD","BK4533","BK4605","AMGN","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE0009355771.USD","SOXX","LU2357627491.SGD","IE000F7OJYX1.SGD","LU0097036916.USD","QQQA","CHPS","HK0000304805.HKD","LU1571399168.USD","LU2148611432.USD","PPH","LU0742534661.SGD","LU0868494617.USD","BK4529","BK4575","BIB","BK4585","LU0211331839.USD","LU0208291251.USD","BK4550","LU2468319806.SGD","INTC","LU0187121727.USD","INT","LU0859254822.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU0719512351.SGD","AIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666031372","title":"Protagonist Therapeutics Launches USD 300 Million Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics launches USD 300 million share buyback programProtagonist Therapeutics launched a share repurchase program for up to USD 300 million of outstanding common stock.Funding planne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc74SRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU2750360641.GBP","LU1778281490.HKD","LU1551013342.USD","PTGX","IYH","LU2430703095.HKD","LU2468319806.SGD","LU2487616109.SGD","LU0689472784.USD","LU1718418525.SGD","RXL","LU1244550221.USD","TRUH","LU1267930813.SGD","XLV","IE00BGHQF631.EUR","IE0009355771.USD","LU1057294990.SGD","SGXZ80539844.SGD","LU1032955483.USD","JNJ","IE00BDGV0183.EUR","LU0820562030.AUD","IXJ","BK4533","SG9999001176.SGD","MEDX","GDOC","BK4504","FTXH","IE0002141913.USD","IE00B19Z3B42.SGD","JDOC","LU1145028129.USD","BK4007","IE00BFXG1179.USD","IHE","LU1506573853.SGD","BMED","LU0058720904.USD","LU2602419157.SGD","SG9999001440.SGD","IE00B4R5TH58.HKD","PJP","IE00B42XCP33.USD","LU1066051225.USD","VHT","BK4588","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","XPH","BME","IDNA","MEDX","WDNA","PJP","BBP","GNOM","FHLC","IBBJ","PBPH","BIB","JDOC","CURE","TBXU","PINK","IEIH","FTXH","MEDI","CANC","LFSC","HYLG","PTH","AZNH","CNCR","GNMX","GPCR","GSKH","IBBQ","PSCH","FXH","APXH","MNTL","MRNY","BBH","PSIL","LLYX","MDTX","NVIB","GDOC","JHMH","HRTS","PBE","RSPH","FBT","SBIO","SYNB","SURI","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666631372","title":"Headlands Research Names Brandon Pallott Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666631372","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666631372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:17","pubTimestamp":1788895060,"startTime":"0","endTime":"0","summary":"Headlands Research names Brandon Pallott chief commercial officerHeadlands Research appointed Brandon Pallott as chief commercial officer to lead business development and commercial strategy, reportin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL75psbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","VHT","IXJ","LU0417517546.SGD","IE00BDGV0183.EUR","LU1236620750.USD","LU2468319806.SGD","LU0820561818.USD","BK4588","LU2087621335.USD","MEDX","FHLC","TRUH","LU0124676726.USD","ABBV","IE000F7OJYX1.SGD","LU2357627491.SGD","BK4585","AGNG","LU2237443895.HKD","LU1162221912.USD","LU1496350502.SGD","LU2023251221.USD","IE0002270589.USD","PJP","RXL","SG9999011175.SGD","SG9999015978.USD","LU0310799852.SGD","FTXH","LU2089283258.USD","IYH","LU1670628061.USD","LU2089284900.SGD","LU2347655156.SGD","PPH","LU0203345920.USD","LU0211328371.USD","LU0868494617.USD","LU0320765646.SGD","LU0965509101.SGD","LU1023059063.AUD","IE000WAW04H5.SGD","SG9999003800.SGD","XLV","JDOC","LU0456855351.SGD","LU0868494708.USD","LU2129689514.USD","LU1003077747.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU0689472784.USD","HRTS","LU0210536198.USD","LU0683600562.USD","OZEM","LU2462591350.SGD","LU0353189763.USD","LU1814569148.SGD","SG9999018857.SGD","LU0672654240.SGD","LU2750360641.GBP","LU0316494557.USD","LU1145028129.USD","LU2168563687.JPY","LU2471134879.HKD","LU2357305700.SGD","LU0708995401.HKD","LU0345770993.USD","LU1127390331.HKD","LU0320765059.SGD","LU0320765992.SGD","LU0203202063.USD","LU0882574139.USD","LU2168564222.USD","LU2089284900.SGD","LU0964807845.USD","LU0133085943.USD","LU2236285917.USD","IHE","MHIP","LU0106261372.USD","LU2552382132.HKD","GDOC","SGXZ81514606.USD","LU2756315664.SGD","LU2471134952.CNY","LU2264538146.SGD","IE0005OL40V9.USD","LU0820562030.AUD","LU1989771016.USD","LU0234572021.USD","LU2237443895.HKD","LU1720051108.HKD","LU1983299246.USD","LU0823416689.USD","LU0943347566.SGD","SG9999013999.USD","LU1804176565.USD","LU2265009873.SGD","SG9999015952.SGD","LU0289739699.SGD","IXJ","IYH","IE00B7KXQ091.USD","LU1974910355.USD","IE00B1BXHZ80.USD","LU2461242641.AUD","LU0353189680.USD","LU2023251221.USD","LU2237443382.USD","LU2168564495.EUR","BK4516","IE00BK4W5L77.USD","LU0006306889.USD","LU1868837300.USD","THNR","LU1868837136.USD","LU2168564149.EUR","LLII","IE00B1XK9C88.USD","IE00BJLML261.HKD","LU2456880835.USD","LU0225283273.USD","LU2112291526.USD","LU0432979614.USD","SG9999014898.SGD","BK4588","LU2361044865.SGD","LU0354030511.USD","LU2023250330.USD","LU0820561909.HKD","LU2023250504.SGD","LU0109391861.USD","LU1069344957.HKD","LU2237443978.SGD","IE00BJJMRZ35.SGD","WDNA","PPH","LU0094547139.USD","IE0004445015.USD","LU0238689110.USD","LU1548497426.USD","LU1988902786.USD","LU2324357040.USD","LU0079474960.USD","LU2552382058.USD","RXL","LU2237443465.HKD","LU2746668461.USD","SG9999015978.USD","CANC","XLV","LU0174119429.USD","LU0882574055.USD","LU0456855351.SGD","LU1291159041.SGD","LU1979441026.SGD","LU1366192091.USD","LU1629891620.HKD","LU0640476718.USD","LU0109394709.USD","LU0471298777.SGD","LU1280957306.USD","LU2602419157.SGD","LU2361044949.HKD","LU1551013342.USD","MEDI","LU0471298694.HKD","LU0823434740.USD","LU2087625088.SGD","AGNG","LU0820561818.USD","LU1868836914.USD","LU2417539215.USD","LU2468319806.SGD","SG9999014914.USD","BK4007","LU2271345857.HKD","LU0203201768.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0889565916.HKD","LU0787776722.HKD","LU2750360997.AUD","IE00BWXC8680.SGD","IE0002141913.USD","IE00B4JS1V06.HKD","LU2491050154.USD","LU1720051017.SGD","LU2361045086.USD","SG9999014906.USD","SGXZ99366536.SGD","LU0114720955.EUR","SGXZ31699556.SGD","SG9999001176.SGD","LU1551013425.SGD","LU0823434583.USD","LU2237443622.USD","IE0001KFT4U8.USD","LU1323610961.USD","CURE","MEDX","LU2111349929.HKD","IE00BJJMRY28.SGD","LU1917777945.USD","LU0466842654.USD","IE00B775H168.HKD","LU0058720904.USD","LU0096364046.USD","LU1035775433.USD","LU2491050071.SGD","SG9999001176.USD","IE00BFSS8Q28.SGD","LLYZ","LU1623119135.USD","LU0323591593.USD","LU1868836591.USD","IE00BJT1NW94.SGD","LU2106854487.HKD","LU2211815571.USD","ILDR","LU2552382215.SGD","IE00BN29S564.USD","BK4534","BK4599","GB00BDT5M118.USD","LU0256863811.USD","BK4533","LU2108987350.USD","SG9999015986.USD","IE0009355771.USD","LU1093756325.SGD","LU2746668974.SGD","LU2896262040.SGD","LU1267930730.SGD","LU0345770308.USD","ELIL","LLYX","LU2168564065.EUR","BK4581","IE00BKPKM429.USD","LU1868836757.USD","ELIS","LU1691799644.USD","VHT","IE00BFSS7M15.SGD","LU2237443549.SGD","LU2360106947.USD","LU2491049909.HKD","SGXZ57979304.SGD","IE00BKDWB100.SGD","LU0158827948.USD","IE00BK4W5M84.HKD","IE0004445239.USD","FTXH","LLY","LU1057294990.SGD","LU1232071149.USD","LU2089283258.USD","LU1093756168.USD","LU2089984988.USD","LU2213496289.HKD","SG9999015945.SGD","SG9999014880.SGD","IE00BJJMRX11.SGD","LU0266013472.USD","LU0256863902.USD","LU2063271972.USD","LU2462157665.USD","LU0354030438.USD","LU1061106388.HKD","LU0158827781.USD","JDOC","LU0786609619.USD","SGXZ51526630.SGD","LU2471134796.USD","LU1712237335.SGD","TRUH","LU1064131342.USD","LU2028103732.USD","FHLC","PJP","LU2756315318.SGD","SG9999018865.SGD","LU1023059063.AUD","LU0198837287.USD","SG9999017495.SGD","LU0122379950.USD","LU0417517546.SGD","LU0385154629.USD","LU2471134523.USD","TMED","BK4585","LU0097036916.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":4,"totalSize":299,"code":"91000000","status":"200"}]}}